EPISODE · Nov 17, 2017 · 1 MIN
APCC 2017 Interviews - Chris Sweeney 2
from Talking Urology Podcast · host Talking Urology
Chris Sweeney discusses which is best? Abiraterone vs docetaxal with ADT for hormone naïve metastatic prostate cancer
What this episode covers
Chris Sweeney discusses which is best? Abiraterone vs docetaxal with ADT for hormone naïve metastatic prostate cancer
NOW PLAYING
APCC 2017 Interviews - Chris Sweeney 2
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m